{"paper_id":"943712fb-a49d-433a-98c4-3b6af310f5d6","body_text":"Abstract\nThe recent development of vitrification has completely changed the way we consider today freezing (oocytes and embryos). Based on the excellent outcomes obtained after warming, a different new range of indications has evolved in the last few years. One of the main ones is oocyte freezing for medical and nonmedical indications. Whereas oocyte freezing for fertility preservation is not considered experimental anymore and is socially well accepted, social oocyte freezing is still controversial. In between these two indications (oncological and social), we have medical indications for social freezing that are not oncological conditions, such as endometriosis. The reason to consider oocyte freezing in these particular group of women would be the risk of losing their reproductive potential with the progression of the disease or after radical surgery if needed, as well as to avoid the psychological pressure of having a progressive disease that may be deleterious for their future fertility. Although data is scarce, we will review the indications as well as the outcome in women with endometriosis, and discuss the pros and cons of this procedure, supported by recent data from our group.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nCobo A, Giles J, Paolelli S, Pellicer A, Remohí J, García-Velasco JA. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril. 2020;113(4):836–44.\nGarcia-Fernandez J, García-Velasco JA. Endometriosis and reproduction: what we have learned. Yale J Biol Med. 2020;93:571–7.\nMathieu d’Argent E, Ferrier C, Zacharopoulou C, Ahdad-Yata N, Boudy AS, Cantalloube A, Levy R, Antoine JM, Daraï E, Bendifallah S. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols. J Ovarian Res. 2020;13:18.\nGupta S, Agarwal A, Agarwal R, de Mola JR. Impact of ovarian endometrioma on assisted reproduction outcomes. Reprod Biomed Online. 2006;13(3):349–60.\nLlarena NC, Falcone T, Flyckt RL. Fertility preservation in women with endometriosis clinical medicine insights. Reprod Health. 2019;13:1–8.\nBusacca M, Riparini J, Somigliana E, Oggioni G, Izzo S, Vignali M, Candiani M. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol. 2006;195:421–5.\nYounis JS, Shapso N, Fleming R, Ben-Shlomo I, Izhaki I. Impact of unilateral versus bilateral ovarian endometriotic cystectomy on ovarian reserve: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:1–17.\nCalagnaa G, Della Corte L, Giampaolino P, Maranto M, Perino A. Endometriosis and strategies of fertility preservation: a systematic review of the literature. Eur J Obstet Gynecol Reprod Biol. 2020;254:218–25.\nSanchez AM, Vanni VS, Bartiromo L, Papaleo E, Zilberberg E, Candiani M, Orvieto R, Viganò P. Is the oocyte quality affected by endometriosis? A review of the literature. J Ovarian Res. 2017;10:43.\nBenaglia L, Somigliana E, Vercellini P, Abbiati A, Ragni G, Fedele L. Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation. Hum Reprod. 2009;24:2183–6.\nNakahara K, Saito H, Saito T, Ito M, Ohta N, Takahashi T, Hiroi M. Ovarian fecundity in patients with endometriosis can be estimated by the incidence of apoptotic bodies. Fertil Steril. 1998;69(5):931–5.\nOrazov MR, Radzinsky VY, Ivanov II, Khamoshina MB, Shustova VB. Oocyte quality in women with infertility associated endometriosis. Gynecol Endocrinol. 2019;35(suppl 1):24–6.\nKitajima M, Dolmans MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101(4):1031–7.\nHsu AL, Townsend PM, Oehninger S, Castora FJ. Endometriosis may be associated with mitochondrial dysfunction in cumulus cells from subjects undergoing in vitro fertilization-intracytoplasmic sperm injection, as reflected by decreased adenosine triphosphate production. Fertil Steril. 2015;103:347–52.\nGarcia-Velasco JA, Arici A. Is the endometrium or oocyte/embryo affected in endometriosis? Hum Reprod. 1999;14:77–89. https://doi.org/10.1093/humrep/14.suppl_2.77.\nBoucret L, Bouet P-E, Riou J, Legendre G, Delbos L, El Hachem H, Descamps P, Reynier P, May-Panloup P. Endometriosis lowers the cumulative live birth rates in IVF by decreasing the number of embryos but not their quality. J Clin Med. 2020;9:2478. https://doi.org/10.3390/jcm9082478.\nNieweglowska D, Hajdyla-Banas I, Pitynski K, Banas T, Grabowska O, Juszczyk G, Ludwin A, Jach R. Age-related trends in anti-Mullerian hormone serum level in women with unilateral and bilateral ovarian endometriomas prior to surgery. Reprod Biol Endocrinol. 2015;13:128.\nLemos NA, Arbo E, Scalco R, Weiler E, Rosa V, Cunha-Filho JS. Decreased anti-Mullerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis. Fertil Steril. 2008;89(5):1064–8.\nSanchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20(2):217–30.\nBarra F, Laganà AS, Scala C, Garzon S, Ghezzi F, Ferrero S. Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reprod Biomed Online. 2020;41(5):859–68.\nPluchino N, Roman H. Oocyte vitrification offers more space for a tailored surgical management of endometriosis. Reprod Biomed Online. 2020;41(5):753–5.\nMarcoux S, Maheux R, Bérubé S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. N Engl J Med. 1997;337:217–22. https://doi.org/10.1056/NEJM199707243370401.\nKim SJ, Kim SK, Lee JR, Suh CS, Kim SH. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis. Reprod Biomed Online. 2020;40(6):827–34.\nBenaglia L, Busnelli A, Biancardi R, Vegetti W, Reschini M, Vercellini P, Somigliana E. Oocyte retrieval difficulties in women with ovarian endometriomas. Reprod Biomed Online. 2018;37(1):77–84.\nRomero B, Aibar L, Navarro LM, Fontes J, Calderón MA, Mozas J. Pelvic abscess after oocyte retrieval in women with endometriosis: a case series. Iran J Reprod Med. 2013;11(8):677–80.\nYounis JS, Ezra Y, Laufer N, Ohel G. Late manifestation of pelvic abscess following oocyte retrieval, for in vitro fertilization, in patients with severe endometriosis and ovarian endometriomata. J Assist Reprod Genet. 1997;14(6):343–6.\nGuo H, Wang Y, Chen Q, Chai W, Sun L, Ai A, Fu Y, Lyu Q, Kuang Y. Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization. Sci Rep. 2017;7(1):1–10.\nDrakopoulos P, Blockeel C, Stoop D, Camus M, de Vos M, Tournaye H, Polyzos NP. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? Hum Reprod. 2016;31(2):370–6.\nBastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, Buyru F. Comparison of ovulation induction protocols after endometrioma resection. JSLS. 2014;18(3):e2014.\nZhao F, Lan Y, Chen T, Zhimin Xin Y, Liang YL, Wang S, Zhang J, Yang X. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study. J Ovarian Res. 2020;13:23.\nCantor A, Tannus S, Son WY, Tan SL, Dahan MH. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF. Reprod Biomed Online. 2019;38(4):520–7.\nLantsberg D, Fernando S, Cohen Y, Rombauts L. The role of fertility preservation in women with endometriosis: a systematic review. J Minim Invasive Gynecol. 2019;27(2):362–72.\nDiaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, Cobo A, Remohí J, Pellicer A. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2017;109(3):478–85.\nKristensen SG, Andersen CY. Cryopreservation of ovarian tissue: opportunities beyond fertility preservation and a positive view into the future. Front Endocrinol. 2018;9:347.\nAndersen CY, Mamsen LS, Kristensen SG. Fertility preservation: freezing of ovarian tissue and clinical opportunities. Reproduction. 2019;158(5):F27–34.\nSuzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, Morimoto Y, Kawamura K. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30(3):608–15.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG\nAbout this chapter\nCite this chapter\nD’Allagnol, H., Cobo, A., Garcia-Velasco, J.A. (2022). Fertility Preservation in Endometriosis. In: Oral, E. (eds) Endometriosis and Adenomyosis. Springer, Cham. https://doi.org/10.1007/978-3-030-97236-3_22\nDownload citation\nDOI: https://doi.org/10.1007/978-3-030-97236-3_22\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-030-97235-6\nOnline ISBN: 978-3-030-97236-3\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}